0.8700USD-3.23%Mkt Cap: 25.19M USDP/E: —Last update: 2026-05-22
Celularity Inc., a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, inclu…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap25.19M USD
Enterprise Value94.85M USD
Revenue (TTM)26.55M USD
Gross Profit6.48M USD
Net Income (TTM)-91.72M USD
Revenue/Share1.037 USD
Last Price0.8700 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.58
PEG—
EV/EBITDA-1.76
EV/Revenue3.57
P/S0.98
P/B-0.68
EPS (TTM)-3.59
EPS (Forward)-0.57
52W Range
0.71004% of range4.350
52W High4.350 USD
52W Low0.7100 USD
Profitability
Gross Margin24.39%
Oper. Margin-492.15%
EBITDA Margin-203.44%
Profit Margin-345.45%
ROE240.96%
ROA-85.45%
Growth
Revenue Growth-77.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.25M USD
CapEx (TTM)—
FCF Margin-19.80%
FCF Yield-20.87%
Net Debt68.54M USD
Net Debt/EBITDA-1.27
Balance Sheet
Debt/Equity-1.07
Current Ratio0.15
Quick Ratio0.14
Book Value/Sh-1.3200 USD
Cash/Share0.2130 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateFeb 29, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.28.95M
Float18.82M
Insiders36.41%
Institutions12.77%
Short Interest
Short Ratio8.0d
Short % Float4.13%
Short % Out.0.95%
Shares Short275.41K
Short (prev mo.)294.64K
Technical
SMA 501.117 (-22.1%)
SMA 2001.710 (-49.1%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)146.55K
Avg Vol (10d)166.96K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—